Kosch M, Hausberg M, Vormbrock K, Kisters K, Gabriels G, Rahn K H, Barenbrock M
Department of Internal Medicine D, University of Münster, Albert-Schweitzer-Strasse 33, D-48129, Münster, Germany.
Cardiovasc Res. 2000 Sep;47(4):813-8. doi: 10.1016/s0008-6363(00)00130-9.
The endothelium is a newly recognised target tissue of parathyroid hormone (PTH). It is not clear whether hyperparathyroidism affects endothelial function and whether parathyroidectomy (Ptx) has an influence on arterial vessel wall properties. We studied brachial flow-mediated vasodilation (FMD) and brachial and carotid intima-media thickness (IMT) in patients with primary hyperparathyroidism (pHPT) before and after Ptx and in healthy controls.
19 patients with pHPT (mean+SEM, age 45+/-4.7 years, PTH 238+/-52 ng/l) were studied. Diabetes, hypertension and vascular disease were excluded. Twenty healthy volunteers matched for age, sex and blood pressure served as controls. Enddiastolic diameter, FMD and nitroglycerine-induced (NMD) dilation of the brachial artery were measured by a multigate pulsed doppler system (echo-tracking), IMT was determined using automatic analysis of the M-line signal. Healthy volunteers where studied on one occasion, patients were studied at baseline and 6 months after Ptx.
Six months after Ptx PTH had decreased to normal, blood pressure levels remained unchanged. Endothelium dependent FMD at baseline was impaired in patients compared to controls (4.7+/-1.2 vs. 18.2+/-3.7%, P<0.01), however, FMD improved significantly after Ptx (16.7+/-3.0%, P<0.01). Nitroglycerine-induced dilation, IMT and artery diameter were not different between groups and did not change after Ptx.
Impaired endothelium dependent vasodilation in patients with primary hyperparathyroidism improves after successful parathyroidectomy. Endothelial dysfunction associated with primary hyperparathyroidism occurs without detectable structural wall alterations of the brachial artery and appears therefore to be an early and reversible arterial alteration.
内皮是甲状旁腺激素(PTH)新确认的靶组织。目前尚不清楚甲状旁腺功能亢进是否会影响内皮功能,以及甲状旁腺切除术(Ptx)是否会对动脉血管壁特性产生影响。我们研究了原发性甲状旁腺功能亢进症(pHPT)患者在Ptx前后以及健康对照者的肱动脉血流介导的血管舒张(FMD)以及肱动脉和颈动脉内膜中层厚度(IMT)。
研究了19例pHPT患者(平均±标准误,年龄45±4.7岁,PTH 238±52 ng/L)。排除了糖尿病、高血压和血管疾病。20名年龄、性别和血压匹配的健康志愿者作为对照。使用多门脉冲多普勒系统(回声跟踪)测量肱动脉的舒张末期直径、FMD和硝酸甘油诱导的(NMD)舒张,使用M线信号的自动分析确定IMT。健康志愿者仅进行一次研究,患者在基线时和Ptx后6个月进行研究。
Ptx后6个月,PTH降至正常,血压水平保持不变。与对照组相比,患者基线时内皮依赖性FMD受损(4.7±1.2 vs. 18.2±3.7%,P<0.01),然而,Ptx后FMD显著改善(16.7±3.0%,P<0.01)。硝酸甘油诱导的舒张、IMT和动脉直径在各组之间无差异,且Ptx后未发生变化。
原发性甲状旁腺功能亢进症患者成功进行甲状旁腺切除术后,内皮依赖性血管舒张功能受损得到改善。与原发性甲状旁腺功能亢进症相关的内皮功能障碍在肱动脉无明显结构壁改变的情况下发生,因此似乎是一种早期且可逆的动脉改变。